January 20, 2026
Jess Herstine Publishes Commentary in Molecular Therapy Methods & Clinical Development
Congratulations to Jess Herstine for publishing a first-author commentary in Molecular Therapy Methods & Clinical Development!
The commentary is titled, "To be or not to PHP.eB? Potential strategies for therapeutically "attacking" multiple sclerosis".
